[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
Understand the COVID-19 Outbreak and its impact on global & regional businesses
request free proposal
Insights on a world turned upside down : Re-imagining
The post-COVID19 Business resilience & recovery
How effective strategies and business recovery plans are winning the race
request free proposal
Goldstein Market Intelligence help you navigate through the COVID-19 crisis,
we will provide you most relevant market insights on crisis management,
recovery strategy & business continuity.
2019-06-18
340
Global
Biopharmaceuticals & biomedicine deals with the research and development of drugs (biologics) partially or completely using biological compounds. The year 2017 has witnessed huge growth in biopharmaceutical industry. Biomedicines are increasingly penetrating the market as the drug manufacturers and other pharmaceutical companies are inclining towards R&D of biomedicine. Thus continuous R&D, approval and huge pipeline of biomedicine and biopharmaceutical products are driving the growth of the industry. In 2017, US FDA has approved 56 new medicines, which is highest in past 2 decades. Oncology biopharmaceutical is one the most attractive segment, ensuring better treatment to the cancer and tumor patients. Although the prices of biomedicine are higher than branded medicines but effectiveness and quick response of biomedicine is keeping up the demand and over the forecast period (2017-2025) it is anticipated to have larger market share of the pharmaceutical industry.
Our Global Biopharmaceutical & Biomedicine Market can be segmented on the following basis:
Based on Biopharmaceuticals & Biomedicine Branch
Based on Implications
Based on Application
Based on Geography
Key Players Mentioned In the Report
Amgen, Merck Serono, Roche, Biogen, Inc., Gilead Sciences, Inc., Genzyme, MedImmune, Celltech Group plc, Boehringer Ingelheim, Novartis, Biocon, AbbVie, Teva and many more.
Asia Pacific Biopharmaceutical & Biomedicine Industry: Investments in Asia Pacific region is a new trend in the biopharmaceutical industry. China Food and Drug Administration (CFDA) is expected to be flooded with the approval and launch of new products. The CFDA is witnessed in past 3 years to come up with reforms in the industry. Moreover, Japan Ministry of Health, Labor and Welfare (MHLW) has also made price reforms impacting the in-market drugs price revision and also the new drugs. Similarly, South Asia biopharmaceutical industry is also witnessing high growth waves.
Competition Analysis: Biopharmaceutical & biomedicine have changed the landscape of competition in the pharmaceutical industry. The branded drug manufacturers and pharmaceuticals as seen till now were in competition with the generic drug manufacturers. Whereas, now the branded drug manufacturers are likely to shift their interest towards biopharmaceutical products. Moreover, even the low profit margin in the manufacturing and marketing of biopharmaceutical products & biomedicine, the companies are witnessed to incline towards them owing to the future growth prospects of the biopharmaceutical industry.
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity , Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region with Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User & by Region with Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024
Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024